search
Back to results

Home Monitoring in Pediatric Heart Failure (HOPE-HF)

Primary Purpose

Pediatric Heart Failure

Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
DynaVision System
Sponsored by
Bambino Gesù Hospital and Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Pediatric Heart Failure

Eligibility Criteria

1 Month - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • NYHA/Ross class III or IV
  • Severe impairment of ventricular function (EF < 40%) both for left or univentricular
  • Prior hospitalization for acute heart failure within 1 year
  • At least 2 prior hospitalization for acute heart failure
  • Patients on waiting list for orthotopic heart transplantation (UNOS 1B,2)
  • Informed consent obtained

Exclusion Criteria:

  • PMK or ICD
  • hospitalized patients
  • neurological or psychiatric impairment
  • urgent waiting list for heart transplantation (UNOS 1A)

Sites / Locations

  • Bambino Gesù Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Telemonitoring

Arm Description

To evaluate the feasibility and efficacy of a new model of tele monitoring in pediatric population in advanced heart failure, we will enroll 20 patients in advanced NYHA/Ross class in waiting list for Heart Transplant. An home telemonitoring capable to detect vital parameters as heart rate, body temperature, blood pressure, oxygen saturation, breathe frequency, weight, arrhythmias and cardiac index may offers to physician valuable information able to strictly monitoring the clinical status of patients

Outcomes

Primary Outcome Measures

Primary outcome
number of day (percentage) of adherence to telemonitoring, at least 18 hours per day when the patient kept the patch applied at 3 months.

Secondary Outcome Measures

Number of hours of patch kept applied
Tolerability
Number of hours of patch kept applied
Tolerability
Interquartile Range - median of hours of patch kept applied
Tolerability
Interquartile Range - median of hours of patch kept applied
Tolerability
Number of unplanned hospitalization
Reliability
Number of life treating arrhythmias
Reliability
Mortality
Reliability
Number of unplanned hospital access (day hospital / ambulatory)
Reliability
Comparison to levels of Hemoglobin (g/dL)
Reliability
Comparison to levels of Albumin (g/dL)
Reliability
Comparison to levels of Sodium (mEq/L)
Reliability
Comparison to levels of Potassium (mEq/L)
Reliability
Comparison to levels of Serum Creatinine (mg/dL)
Reliability
Satisfaction questionnaire
Satisfaction
Satisfaction questionnaire
Satisfaction

Full Information

First Posted
March 11, 2021
Last Updated
August 18, 2021
Sponsor
Bambino Gesù Hospital and Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT05017077
Brief Title
Home Monitoring in Pediatric Heart Failure
Acronym
HOPE-HF
Official Title
Home Telemonitoring in Pediatric Heart Failure
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
September 1, 2021 (Anticipated)
Primary Completion Date
April 1, 2022 (Anticipated)
Study Completion Date
April 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Bambino Gesù Hospital and Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Heart failure is a complex clinical syndrome, representing the final evolution of many cardiac diseases that may differ for etiology and pathophysiology. In pediatric population, it is particularly challenging to manage because of the heterogeneity in age, primary cardiac disease, and the broad range of clinical signs and symptoms. Frequent hospitalizations are current problem. Hospitalization within the first year since the first episode, lack of adherence to medical therapy and diet difficulties are the main issues in this population of patients, and they rebounds on prognosis and public health costs. Actions aimed to prevent and manage these matters will improve outcome in patients with chronic heart failure. Telemedicine proved its usefulness in adult population, but, nowadays, no studies have been conducted in children. From the beginning of 21th century, remote monitoring attempts have been adopted, initially by phone calls. Currently, the e-care monitoring fits in the context of telemedicine 2.0 based on new communication models. The aim of this study is to affirm the feasibility and efficacy of a new model of tele monitoring in pediatric population. High-risk patients need a strict clinical control normally difficult to adopt. A telematics system capable to detect vital parameters as heart rate, body temperature, blood pressure, oxygen saturation, breathe frequency, weight, arrhythmias and cardiac index may offers to physician valuable information able to strictly monitoring the clinical status of patients. All of these data permits to physician to early detect critical signals of a deteriorated status, modify adherence to care and implement therapeutic strategies in order to prevent frequent hospitalizations. Our project provides a system of continuous tele-monitoring of vital parameters through a patch applied on the chest of the baby. Data are sent to a service center, "virtual clinic" and daily analyzed in multiparametric system by a specialized nurse. On the basis of pre-established alarms, the virtual clinic will notify to physician. Feasibility and tolerability of this new monitoring system will be evaluated after a 3 months period on a cohort of 20 patients affected by chronic, high-risk, heart failure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pediatric Heart Failure

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Telemonitoring
Arm Type
Experimental
Arm Description
To evaluate the feasibility and efficacy of a new model of tele monitoring in pediatric population in advanced heart failure, we will enroll 20 patients in advanced NYHA/Ross class in waiting list for Heart Transplant. An home telemonitoring capable to detect vital parameters as heart rate, body temperature, blood pressure, oxygen saturation, breathe frequency, weight, arrhythmias and cardiac index may offers to physician valuable information able to strictly monitoring the clinical status of patients
Intervention Type
Device
Intervention Name(s)
DynaVision System
Intervention Description
Telemonitoring for pediatric heart failure
Primary Outcome Measure Information:
Title
Primary outcome
Description
number of day (percentage) of adherence to telemonitoring, at least 18 hours per day when the patient kept the patch applied at 3 months.
Time Frame
three months
Secondary Outcome Measure Information:
Title
Number of hours of patch kept applied
Description
Tolerability
Time Frame
at 1 week
Title
Number of hours of patch kept applied
Description
Tolerability
Time Frame
at 3 months
Title
Interquartile Range - median of hours of patch kept applied
Description
Tolerability
Time Frame
at 1 week
Title
Interquartile Range - median of hours of patch kept applied
Description
Tolerability
Time Frame
at 3 months
Title
Number of unplanned hospitalization
Description
Reliability
Time Frame
3 months
Title
Number of life treating arrhythmias
Description
Reliability
Time Frame
3 months
Title
Mortality
Description
Reliability
Time Frame
3 months
Title
Number of unplanned hospital access (day hospital / ambulatory)
Description
Reliability
Time Frame
3 months
Title
Comparison to levels of Hemoglobin (g/dL)
Description
Reliability
Time Frame
3 months
Title
Comparison to levels of Albumin (g/dL)
Description
Reliability
Time Frame
3 months
Title
Comparison to levels of Sodium (mEq/L)
Description
Reliability
Time Frame
3 months
Title
Comparison to levels of Potassium (mEq/L)
Description
Reliability
Time Frame
3 months
Title
Comparison to levels of Serum Creatinine (mg/dL)
Description
Reliability
Time Frame
3 months
Title
Satisfaction questionnaire
Description
Satisfaction
Time Frame
1 week
Title
Satisfaction questionnaire
Description
Satisfaction
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Month
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: NYHA/Ross class III or IV Severe impairment of ventricular function (EF < 40%) both for left or univentricular Prior hospitalization for acute heart failure within 1 year At least 2 prior hospitalization for acute heart failure Patients on waiting list for orthotopic heart transplantation (UNOS 1B,2) Informed consent obtained Exclusion Criteria: PMK or ICD hospitalized patients neurological or psychiatric impairment urgent waiting list for heart transplantation (UNOS 1A)
Facility Information:
Facility Name
Bambino Gesù Hospital
City
Rome
ZIP/Postal Code
00165
Country
Italy

12. IPD Sharing Statement

Learn more about this trial

Home Monitoring in Pediatric Heart Failure

We'll reach out to this number within 24 hrs